Endoscopic removal for small rectal neuroendocrine tumors
Part of Cancer, Digestive system clinical trials.
This trial tests two endoscopic techniques (mEMR-C and mEMR-L) to remove small rectal neuroendocrine tumors. It may help patients with tumors 10 mm or smaller who want a less invasive treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- A tumor in your rectum is suspected or confirmed to be a neuroendocrine tumor (NET) based on a special scope exam.
- The tumor is 10 millimeters or smaller when measured by colonoscopy.
- You are planning to get one of the study treatments (mEMR-C or mEMR-L) and have signed a consent form.
- You do not have serious health issues (like other cancers) that would shorten your life or make the procedure unsafe.
- The tumor has not spread to lymph nodes or other parts of your body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at removing small rectal neuroendocrine tumors using an endoscope (a thin camera tool) instead of open surgery. It may help people with very small tumors if the doctors think you can safely have this procedure and the cancer has not spread to lymph nodes or distant organs.
This study compares two minimally invasive ways to remove small rectal neuroendocrine tumors (NETs), which are growths in the rectum that are usually not cancer. The goal is to find which method is safer and more effective with fewer side effects.
This trial compares two minimally invasive methods to remove small rectal neuroendocrine tumors (less than 1 cm) during a colonoscopy. It may help patients avoid major surgery while still effectively treating the tumor.
This study compares two minimally invasive endoscopic techniques—ESD and EPMR—for removing small neuroendocrine tumors (slow-growing hormone-producing tumors) in the rectum. The goal is to see which approach works better and is safer for patients.
This trial tests whether removing lymph nodes in the pelvis during laparoscopic surgery for rectal neuroendocrine tumors (a type of slow-growing or aggressive tumor) improves outcomes. It is for people with larger or recurrent tumors, or those at higher risk due to tumor grade or depth.
This trial tests a special underwater technique to remove small type I gastric neuroendocrine tumors (5-9 mm) during an endoscopy. The goal is to see if it is safe and effective, which could offer a less invasive treatment option.
Hear when a new Rectal Neuroendocrine Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.